Stirring the entrepreneurial pot in Europe

April 6, 2017 Christoph Graener

Europe is home to many of the biggest pharma companies and the best academic biomedical researchers. But the US is the dominant place with thriving hubs of biotech entrepreneurs, people taking big risk and creating much of the value in healthcare. Quite a few countries aspire to create their own dynamic clusters like Boston and San Francisco, but haven’t pulled it off. What is happening today in various European hotspots, at the intersection of academia and entrepreneurship?

Moderator: Luke Timmerman – Timmerman Report

  • Divya Chadha Manek – NIHR
  • Alexander Mayweg – Versant Ventures
  • Antoine Papiernik – Sofinnova Partners
  • Issi Rozen – Broad Institute

Previous Article
Digimed and diagnostics: Market access and new collaborations

The effect of digital medicine on diagnostics is having and will continue to have a revolutionary effect on...

Next Article
Commercializing cell and gene therapies

New business models for clinical development and manufacturing require strategic partnerships among researc...